An Agonistic Antibody to EPHA2 Exhibits Antitumor Effects on Human Melanoma Cells
Sign Up to like & getrecommendations! Published in 2018 at "AntiCancer Research"
DOI: 10.21873/anticanres.12592
Abstract: Background/Aim: EPH receptor A2 (EPHA2) is highly expressed in aggressive types of human cancer, and is expected to be an excellent target molecule for antibody treatments. In this study, we investigated the therapeutic potential of… read more here.
Keywords: agonistic antibody; antibody; human melanoma; antibody epha2 ... See more keywords